Rare diseases
Investigational molecules
Locations
Recruiting trials first
1 clinical trial in this condition
The NetherlandsIn short
Figuring out the stage of cervical cancer is a crucial step that guides the entire treatment journey. Stage 2 cervical cancer means the disease has begun to move beyond the cervix into nearby tissues, but understanding exactly how far it has spread requires careful examination and testing. This process helps doctors create the most effective treatment plan tailored to each person's unique situation.
If you have been told you might have cervical cancer, or if screening tests like a Pap smear (a test that collects cells from the cervix to check for abnormalities) have shown concerning results, your doctor will recommend further diagnostic tests. Stage 2 cervical cancer is often discovered when someone experiences symptoms such as unusual vaginal bleeding, bleeding after sex, watery or bloody discharge with a foul odor, or pain during sex. However, sometimes it is detected through routine screening before symptoms appear.
Anyone with abnormal screening results or symptoms that suggest cervical cancer should seek diagnostic testing without delay. Early and accurate diagnosis is essential because it determines the stage of the cancer, which in turn shapes the treatment approach. For stage 2 cervical cancer specifically, doctors need to understand whether the cancer has spread to the upper vagina, to the tissues surrounding the cervix, or both. This knowledge helps the medical team decide between surgery, radiation, chemotherapy, or a combination of these treatments.
It is advisable to pursue diagnostics as soon as your healthcare provider recommends them. Waiting can allow the cancer to progress, making treatment more complex. If you experience persistent abnormal bleeding, unusual discharge, or pelvic pain, contact your doctor immediately. These symptoms do not always mean cancer, but they warrant investigation. Women between the ages of 35 and 44 are most commonly diagnosed with cervical cancer, but it can occur at any age, especially if regular screening has been missed.
Once cervical cancer is suspected, a series of diagnostic tests are performed to confirm the diagnosis and determine the stage. The first step is usually a pelvic examination, during which the doctor visually inspects the cervix and feels for abnormalities in the uterus, vagina, and nearby organs. This hands-on examination can reveal whether the cancer has spread beyond the cervix into surrounding tissues.
If the pelvic exam or Pap test suggests cancer, the next critical step is a biopsy. During a biopsy, a small sample of tissue is removed from the cervix and examined under a microscope to confirm the presence of cancer cells. There are different types of biopsies, including a simple cervical biopsy, a procedure called colposcopy (where a special magnifying instrument is used to view the cervix in detail), or a cone biopsy (also called conization), which removes a cone-shaped piece of tissue from the cervix. These procedures allow pathologists to see exactly what type of cancer is present and how aggressive it is.
Once cancer is confirmed, imaging tests help determine the stage. Computed tomography scans, or CT scans, use X-rays and a computer to create detailed cross-sectional images of the body. These scans can show whether the cancer has spread to the upper vagina, the tissues around the cervix (called the parametria), or to lymph nodes in the pelvis. Magnetic resonance imaging, or MRI, is another imaging technique that uses magnets and radio waves to produce very detailed pictures of soft tissues. MRI is particularly useful for seeing how deeply the cancer has invaded the cervix and whether it has reached the parametria or vagina.
In some cases, doctors may recommend a PET scan (positron emission tomography), which uses a small amount of radioactive sugar to highlight areas of the body where cancer cells are actively growing. PET scans can help detect cancer that has spread to distant organs or lymph nodes that might not be visible on CT or MRI scans. However, PET scans are not always necessary for stage 2 cervical cancer unless there is a concern about widespread disease.
Ultrasound may also be used, particularly transvaginal ultrasound, where a small probe is inserted into the vagina to create images of the cervix, uterus, and nearby structures. This test can help assess the size of the tumor and whether it has spread to the upper vagina. Blood tests and urine tests are often performed as well to check kidney function, as advanced cervical cancer can sometimes block the flow of urine from the kidneys to the bladder.
The combination of pelvic examination, biopsy, and imaging tests allows doctors to assign a stage to the cancer using the FIGO staging system (from the International Federation of Gynecology and Obstetrics). Stage 2 cervical cancer is divided into two main categories: stage 2A, where the cancer has spread to the upper part of the vagina but not to the parametria, and stage 2B, where the cancer has spread into the parametria but not to the pelvic wall or the lower part of the vagina. Stage 2A is further divided into 2A1 (tumor 4 cm or smaller) and 2A2 (tumor larger than 4 cm).
If you are considering participating in a clinical trial, additional diagnostic tests may be required to determine whether you meet the trial's eligibility criteria. Clinical trials are research studies that test new treatments or combinations of treatments to find better ways to fight cancer. They often have specific requirements about the stage of cancer, the patient's overall health, and previous treatments.
For stage 2 cervical cancer, clinical trials may require confirmation of the cancer stage through biopsy and imaging tests like CT or MRI scans. Some trials may also require additional tests to assess the function of your kidneys, liver, and bone marrow, as certain treatments can affect these organs. Blood tests to measure blood cell counts, kidney function (such as creatinine levels), and liver function (such as liver enzymes) are commonly required before enrollment.
Trials testing new chemotherapy drugs or immunotherapy (treatments that help the immune system fight cancer) may require tests to confirm that your immune system is functioning properly. Some trials also require testing for specific biomarkers, which are substances in the blood or tissue that can indicate how the cancer might respond to certain treatments. For example, some trials may test for HPV status or the presence of certain proteins on cancer cells.
Patients interested in clinical trials should discuss this option with their healthcare team. Your doctor can help determine whether a trial is appropriate for your situation and what tests would be needed to qualify. Participating in a clinical trial can provide access to cutting-edge treatments that are not yet widely available, but it is important to understand the potential risks and benefits before enrolling.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
